72 related articles for article (PubMed ID: 7845013)
41. Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus.
Zimmerman RS; Rosenberg N
J Virol; 2008 Sep; 82(17):8383-91. PubMed ID: 18579612
[TBL] [Abstract][Full Text] [Related]
42. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.
Parmar K; Huebner RC; Rosenberg N
J Virol; 1991 Dec; 65(12):6478-85. PubMed ID: 1942244
[TBL] [Abstract][Full Text] [Related]
43. Abelson transformed fibroblasts lacking the EGF receptor are not tumourigenic in nude mice.
Gebhardt A; Bell JC; Foulkes JG
EMBO J; 1986 Sep; 5(9):2191-5. PubMed ID: 3023060
[TBL] [Abstract][Full Text] [Related]
44. The presence of p53 transformation-related protein in Ab-MuLV transformed cells is required for their development into lethal tumors in mice.
Rotter V; Abutbul H; Wolf D
Int J Cancer; 1983 Mar; 31(3):315-20. PubMed ID: 6298128
[TBL] [Abstract][Full Text] [Related]
45. Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation.
Sexl V; Kovacic B; Piekorz R; Moriggl R; Stoiber D; Hoffmeyer A; Liebminger R; Kudlacek O; Weisz E; Rothammer K; Ihle JN
Blood; 2003 Jun; 101(12):4937-43. PubMed ID: 12576323
[TBL] [Abstract][Full Text] [Related]
46. DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas.
Mushinski JF; Potter M; Bauer SR; Reddy EP
Science; 1983 May; 220(4599):795-8. PubMed ID: 6687762
[TBL] [Abstract][Full Text] [Related]
47. In vitro malignant progression of cells derived from Abelson murine leukaemia virus-induced thymic lymphomas.
Saggioro D; Zamarchi R; D'Andrea E; Chieco-Bianchi L
Br J Cancer; 1988 Aug; 58(2):152-7. PubMed ID: 3262364
[TBL] [Abstract][Full Text] [Related]
48. Selective inhibition of proliferation in v-abl- and bcr-abl-transformed cells by a nucleoside analog.
Cioé L; Mukhopadhyay S; Rovera G
J Biol Chem; 1992 Nov; 267(31):22178-82. PubMed ID: 1331046
[TBL] [Abstract][Full Text] [Related]
49. v-abl does not abolish IL-6 requirement by murine plasmacytoma cells.
Sugiyama H; Wiener F; Babonits M; Silva S; Hirano T; Kishimoto T; Klein G
Int J Cancer; 1991 May; 48(2):234-8. PubMed ID: 2019468
[TBL] [Abstract][Full Text] [Related]
50. The expression of transformation-related protein p53 and p53-containing mRNA in murine RAW117 large cell lymphoma cells of differing metastatic potential.
Rotter V; Wolf D; Nicolson GL
Clin Exp Metastasis; 1984; 2(3):199-204. PubMed ID: 6399697
[TBL] [Abstract][Full Text] [Related]
51. p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells.
Rotter V
Proc Natl Acad Sci U S A; 1983 May; 80(9):2613-7. PubMed ID: 6189126
[TBL] [Abstract][Full Text] [Related]
52. Pre-crisis mouse cells show strain-specific covariation in the amount of 54-kilodalton phosphoprotein and in susceptibility to transformation by simian virus 40.
Chen S; Blanck G; Pollack RE
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5670-4. PubMed ID: 6310588
[TBL] [Abstract][Full Text] [Related]
53. The pathogenesis of tumors induced by helper virus-free Abelson murine leukemia virus.
Green PL; Kaehler D; Risser R
Curr Top Microbiol Immunol; 1988; 141():50-7. PubMed ID: 3215056
[No Abstract] [Full Text] [Related]
54. Experimental control of neoplastic progression in cell populations: Foulds' rules revisited.
Rubin H
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6619-23. PubMed ID: 8022827
[TBL] [Abstract][Full Text] [Related]
55. Comparative research on leukemia and related diseases: an introduction to a scientific approach.
Hehlmann R; Essex M
J Mol Med (Berl); 1997 Jul; 75(7):528-38. PubMed ID: 9253716
[TBL] [Abstract][Full Text] [Related]
56. Increased detection of specific tyrosine phosphoproteins correlates with tumor progression of Abelson virus-infected lymphocytes.
Clark SS; Liang Y
Leukemia; 1995 Jan; 9(1):165-74. PubMed ID: 7845013
[TBL] [Abstract][Full Text] [Related]
57. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
58. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
Clark SS; Liang Y; Reedstrom CK; Wu SQ
Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
[TBL] [Abstract][Full Text] [Related]
59. Multistage progression of Abelson virus-infected murine pre-B-cells to the tumorigenic state.
Palumbo GJ; Ozanne BW; Kettman JR
Cancer Res; 1990 Mar; 50(6):1917-23. PubMed ID: 2155061
[TBL] [Abstract][Full Text] [Related]
60. Transforming pathways activated by the v-Abl tyrosine kinase.
Shore SK; Tantravahi RV; Reddy EP
Oncogene; 2002 Dec; 21(56):8568-76. PubMed ID: 12476303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
